Sepio Capital, LP - MERRIMACK PHARMACEUTICALS IN ownership

MERRIMACK PHARMACEUTICALS IN's ticker is MACK and the CUSIP is 590328209. A total of 65 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 0.58 and the average weighting 0.4%.

Quarter-by-quarter ownership
Sepio Capital, LP ownership history of MERRIMACK PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$3,781,364
+4.4%
306,680
+4.1%
0.33%
+11.2%
Q2 2023$3,622,904
+0.1%
294,5450.0%0.29%
-12.0%
Q1 2023$3,619,958
+7.2%
294,5450.0%0.33%
+14.4%
Q4 2022$3,375,486
+205.5%
294,5450.0%0.29%
+165.5%
Q3 2022$1,105,000
-41.3%
294,545
-6.9%
0.11%
-41.8%
Q2 2022$1,882,000
+0.3%
316,313
+6.7%
0.19%
+14.5%
Q1 2022$1,876,000
+509.1%
296,546
+276.2%
0.16%
+617.4%
Q4 2021$308,000
-19.2%
78,8290.0%0.02%
-25.8%
Q3 2021$381,000
-73.1%
78,829
-64.4%
0.03%
-73.5%
Q2 2021$1,415,000
+2.9%
221,439
+1.2%
0.12%
-7.9%
Q1 2021$1,375,000
+3.2%
218,907
+13.1%
0.13%
+10.4%
Q4 2020$1,333,000
+71.1%
193,476
-0.7%
0.12%
+35.3%
Q3 2020$779,000
+11.1%
194,785
-7.5%
0.08%
+3.7%
Q2 2020$701,000
-7.8%
210,534
-40.5%
0.08%
-18.8%
Q1 2020$760,000
-39.1%
353,644
-10.7%
0.10%
-14.4%
Q4 2019$1,248,000
+20.8%
396,184
+72.6%
0.12%
+10.3%
Q3 2019$1,033,000
-35.0%
229,476
-44.3%
0.11%
-7.8%
Q4 2018$1,589,000411,6760.12%
Other shareholders
MERRIMACK PHARMACEUTICALS IN shareholders Q3 2023
NameSharesValueWeighting ↓
Western Standard LLC 1,894,013$23,353,18021.09%
Newtyn Management, LLC 1,873,694$23,102,6475.70%
Sio Capital Management, LLC 288,466$3,556,7861.10%
Madison Avenue Partners, LP 553,085$6,819,5380.97%
WITTENBERG INVESTMENT MANAGEMENT, INC. 209,739$2,5860.95%
Indaba Capital Management, L.P. 136,802$1,686,7690.50%
Sepio Capital, LP 306,680$3,781,3640.33%
Yakira Capital Management, Inc. 54,118$667,2750.18%
Centiva Capital, LP 187,803$2,315,6110.05%
FIFTH LANE CAPITAL, LP 10,929$134,4270.05%
View complete list of MERRIMACK PHARMACEUTICALS IN shareholders